Suchergebnisse
Vor 5 Tagen · News zur INNOCAN PHARMA AKTIE und aktueller Realtime-Aktienkurs Innocan Pharma beauftragt im Rahmen der Vorbereitungen auf das bevorstehende FDA-Treffen einen Experten für Schmerzmanagement.
IP4 | InnoCan Pharma Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der InnoCan Pharma Aktie Analysiere mit wallstreetONLINE.
InnoCan Pharma: Wichtiges FDA-Update angekündigt! InnoCan Pharma: Meilenstein für die FDA-Zulassung gegen arthritische Schmerzen! Innocan Pharma Aktie: BRUTALE PROGNOSE zwingt Anleger zum...
Innocan Pharma, a leader in the development of innovative CBD delivery methods, has achieved significant goals in 2021. Read more.
1. Apr. 2024 · Gross Profit increased 568% year-over-year to US$12.0 million for the year ended December 31, 2023, compared to US$2.1 million for 2022. Operating loss decreased by 61% to US$3.8 million in 2023 ...
22. Apr. 2024 · With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD release ...
23. Okt. 2023 · In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve...